Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam

NCT01887821 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Vivax Malaria

Interventions

DRUG: Chloroquine
DRUG: Dihydroartemisinin/Piperaquine

Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]